BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 130043)

  • 21. The pharmacology of extrapyramidal movement disorders.
    Klawans HL
    Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serotonin and ATP metabolism in the thrombocytes of patients with different stages of cerebrovascular disorders of the ischemic type].
    Korovin AM; Rudenko IIa; Bogoiavlenskaia NM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(1):32-5. PubMed ID: 760342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experiences with memantine in the treatment of severe spastic and extrapyramidal movement disorders in combination with stereotaxic surgery].
    Mundinger F; Milios E
    Nervenarzt; 1985 Feb; 56(2):106-9. PubMed ID: 3885059
    [No Abstract]   [Full Text] [Related]  

  • 24. [Huntington's chorea and cerebellar atrophy. Apropos of amanatomo-clinical case].
    Castaigne P; Escourolle R; Gray MF
    Rev Neurol (Paris); 1976 Apr; 132(4):233-40. PubMed ID: 132690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion.
    Quinn NP; Rothwell JC; Thompson PD; Marsden CD
    Adv Neurol; 1988; 50():391-401. PubMed ID: 3400498
    [No Abstract]   [Full Text] [Related]  

  • 26. [Catecholamine excretion in torsion dystonia].
    Barkatova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):495-503. PubMed ID: 654723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rigid forms of Huntington's disease (study of a family with an anatomo-clinical case)].
    Delmas-Marsalet P; Bourgeois M; Vital C; Fontanges X
    Rev Neurol (Paris); 1968 Apr; 118(4):273-83. PubMed ID: 4235068
    [No Abstract]   [Full Text] [Related]  

  • 28. [The pathogenetic significance of metabolic disorders in hereditary extrapyramial diseases].
    Tkachev RA; Markova ED; Gotovtseva EV; Bauman LK; Barkhatova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):512-20. PubMed ID: 4250562
    [No Abstract]   [Full Text] [Related]  

  • 29. [Our experience with 420 stereotaxic surgical operations].
    Romodanov AP; Laponogov OA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(5):641-5. PubMed ID: 4330668
    [No Abstract]   [Full Text] [Related]  

  • 30. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease.
    Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM
    Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EFFECT OF ALPHA-METHYL DOPA AND RESERPINE IN HUNTINGTON'S CHOREA, PARKINSON'S DISEASE AND OTHER MOVEMENT DISORDERS.
    MARKHAM CH; CLARK WG; WINTERS WD
    Life Sci (1962); 1963 Sep; 9():697-705. PubMed ID: 14068044
    [No Abstract]   [Full Text] [Related]  

  • 32. Circadian periodicity of plasma prolactin in some neurological diseases.
    Ferrari E; Nappi G; Vailati A; Martignoni E; Bossolo PA; Polleri A
    Int J Chronobiol; 1979; 6(4):231-42. PubMed ID: 162341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Telemetric electromyography in kinesiological investigations in neurology].
    Fasshauer K
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Jun; 13(2):92-9. PubMed ID: 6811246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake of dopamine and 5-hydroxytryptamine by platelets from patients with Huntington's chorea.
    McLean DR; Nihei T
    Lancet; 1977 Jan; 1(8005):249-50. PubMed ID: 64769
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.
    Curtis AR; Fey C; Morris CM; Bindoff LA; Ince PG; Chinnery PF; Coulthard A; Jackson MJ; Jackson AP; McHale DP; Hay D; Barker WA; Markham AF; Bates D; Curtis A; Burn J
    Nat Genet; 2001 Aug; 28(4):350-4. PubMed ID: 11438811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic torsion dystonia associated with lesions of the basal ganglia.
    PeBenito R; Ferretti C; Chaudary RR; Woodrow PK
    Clin Pediatr (Phila); 1984 Apr; 23(4):232-5. PubMed ID: 6697632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serotonin metabolism in patients with brain tumors].
    Makarov AIu; Kiselev VN; Loboda EB; Paniushkin AI; Kozlov SV
    Zh Vopr Neirokhir Im N N Burdenko; 1977; (3):39-44. PubMed ID: 883451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Classification of chronic psychoses types I and II and platelet serotonin levels. Apropos of 38 cases].
    Boudjema F; Terra JL; Guyotat J; Lemoine P; Renaud B; Flachaire E
    Encephale; 1985; 11(1):39-42. PubMed ID: 3996288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.
    Damier P; Thobois S; Witjas T; Cuny E; Derost P; Raoul S; Mertens P; Peragut JC; Lemaire JJ; Burbaud P; Nguyen JM; Llorca PM; Rascol O;
    Arch Gen Psychiatry; 2007 Feb; 64(2):170-6. PubMed ID: 17283284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.